← Back to news
Y

Yahoo Finance

Trump Invokes Defense Act For Monsanto Chemicals: Bayer, Agribusiness ETFs In Focus On New Critical Mineral Status For Phosphorus

Y

Adobe (ADBE) Stock Has Been Beaten Up But the Smart Money Remains Resilient

Y

Should we think more about delaying our retirement to an older age?

Y

Irenic Dumps Most Papa John's Shares

Y

Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash

Y

ExxonMobil Stock Surged 17% in January -- Here's What Drove the Rally (and What You Really Need to Focus On)

Y

AST SpaceMobile (ASTS) Completes $1 Billion Convertible Notes Offering Private

Y

Rocket Lab (RKLB) Launches Cassowary Vex Hypersonic Mission for the U.S. Department of War

Y

IREN (IREN) Added to MSCI USA Index, Boosting Exposure to Institutional Investors

Y

BWS Reiterates Buy on Nebius Group (NBIS) With $130 Target

Y

Reddit (RDDT) Director Buys 50,500 Shares in Major Insider Purchase

Y

Phillip Securities Cuts Palantir (PLTR) Target, Reiterates Buy Rating Again

Y

Needham Raises Micron (MU) Target to $450, Maintains Buy Rating

Y

Mixed Analyst Sentiment on Tesla (TSLA) Post 5 New Collisions in the “Robotaxi” Fleet

Y

Mizuho Reiterates Outperform on Alphabet (GOOGL) With $410 Target Price

Y

Analysts Maintain Buy on Amazon (AMZN) Despite 18% Share Depreciation

Y

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Y

UGI VP Sells 12840 Shares After Net Income Falls in Q1 Earnings

Y

6 Less Common Side Hustles That Fit Perfectly Into a 9-to-5 Schedule

Y

GDX Gold or SLVP Silver: Which ETF Should You Buy Now?

Y

$955 saved for retirement? Millions are in that boat.

Y

Romania About to Break Ground on Biggest Solar Farm in Europe

Y

Pagaya Technologies (PGY) to Exhibit Growth Amid Credit Tightening

Y

PowerFleet (AIOT) Poised to Deliver Strong Returns After an Impressive Quarter

Y

Federal Segment Strength Fuels Optimism Towards Appian (APPN)

Y

Favorable Application SaaS Outlook Bodes Well for Five9 (FIVN)

Y

Progress Software (PRGS) Remains Resilient Against AI-Linked Threats

Y

Here is Why Flywire Corporation (FLYW) Appears so Attractive

Y

Payoneer (PAYO) Strikes Strategic Partnership With Bridge

Y

Allot Limited (ALLT) Transitioning Successfully Towards Security-Centric Consumer Model

Y

Here is What Leads to Attractive Upside on LiveRamp Holdings (RAMP)

Y

Hedge fund billionaire Ray Dalio warned that the US is heading into ‘very dark times.’ How to protect your portfolio

Y

Content creation can be a profitable gig, but you need to follow IRS tax rules. Here's what you need to report and why

Y

4 in 10 Americans aren’t confident about their savings — they may be right if these 3 debts aren’t paid off

Y

Here's Walmart's $1 trillion secret

Y

Global cash is fueling a historic start for Latin America stocks

Y

Nvidia earnings, SCOTUS tariff fallout, geopolitical tensions rise: What to watch this week

Y

HELOC and home equity loan rates Sunday, February 22, 2026: Monthly payments fall (example: $302 a month)

Y

Mortgage and refinance interest rates today, February 22, 2026: Still low (from 5.86% to 6.01%)

Y

Best money market account rates today, February 22, 2026 (best account provides 4.01% APY)

Y

Best CD rates today, February 22, 2026 (lock in up to 4% APY)

Y

Best high-yield savings interest rates today, February 22, 2026 (Earn up to 4% APY)

Y

Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating

Y

Barclays Lowers its Price Target on Ralliant Corporation (RAL) to $52 and Maintains an Overweight Rating

Y

The Taxman Still Cometh, But May Take Away Less

Y

RBC Capital Lowers its Price Target on Figma, Inc. (FIG) to $31 and Maintains a Sector Perform Rating

Y

JBS N.V. (JBS) Reaches an Agreement to Invest $150 Million in Exchange for an 80% Ownership Interest in a Food Business Based in Oman

Y

BofA Reinstates Coverage of NIQ Global Intelligence plc (NIQ) with a Buy Rating and a $20 Price Target

Y

JPMorgan Reduces its Price Target on Bullish (BLSH) to $41 and Maintains a Neutral Rating

Y

KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating

Y